Hemato Oncology Testing Industry Research Report 2023
Hemato Oncology Testing is a technology to predict the probability of disease by collecting genes (DNA) in human blood and analyzing and measuring the complete sequence of genes. Genetic testing can identify individuals' genes for disease, thereby preventing or treating tumours earlier.
Hematologic tumor detection is a technique to detect tumor genes on the basis of gene detection. Blood tumor detection services cover a wide range of solid tumors such as lung cancer, breast cancer, stomach cancer, esophageal cancer, colorectal cancer and liver cancer. Common tumors are detected. According to different tumor stages, blood tumor detection can be divided into four categories: tumor susceptibility gene screening, tumor early diagnosis, tumor individualized drug diagnosis, and tumor recovery monitoring. Tumor susceptibility gene screening can help people at high risk of genetic mutations to actively prevent tumors. Early diagnosis of cancer can help patients to find the disease as early as possible, thus greatly improving the survival rate of cancer patients. Individualized drug diagnosis for cancer patients to provide a more accurate cancer treatment program. Tumor recovery was monitored to assess the risk of recurrence.
In this paper, the current status and future development trend of hematoncology testing in China market are studied, focusing on the analysis of the companies that play an important role in the Chinese market, and focusing on the revenue, market share, market positioning, development plans, products and services of these companies in the Chinese market.
Highlights
The global Hemato Oncology Testing market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
In Chinese Market, Hemato Oncology Testing key players include Roche, Berry Genomics, Burning Rock Dx, BGI, Genetron, etc. Global top 5 manufacturers hold a share over 28%.
In terms of product, ctDNA Testing is the largest segment, with a share over 71%. And in terms of application, the largest application is Hospital, followed by Third Party Agency, Others.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Hemato Oncology Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemato Oncology Testing.
The Hemato Oncology Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Hemato Oncology Testing market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hemato Oncology Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Global markets are presented by Hemato Oncology Testing type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Hemato Oncology Testing are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Hemato Oncology Testing segment by Type
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Hemato Oncology Testing market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Hemato Oncology Testing market.
Hemato Oncology Testing Segment by Application
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Hemato Oncology Testing market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemato Oncology Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Hemato Oncology Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Hemato Oncology Testing industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemato Oncology Testing.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Hemato Oncology Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Frequently Asked Questions
Hematologic tumor detection is a technique to detect tumor genes on the basis of gene detection. Blood tumor detection services cover a wide range of solid tumors such as lung cancer, breast cancer, stomach cancer, esophageal cancer, colorectal cancer and liver cancer. Common tumors are detected. According to different tumor stages, blood tumor detection can be divided into four categories: tumor susceptibility gene screening, tumor early diagnosis, tumor individualized drug diagnosis, and tumor recovery monitoring. Tumor susceptibility gene screening can help people at high risk of genetic mutations to actively prevent tumors. Early diagnosis of cancer can help patients to find the disease as early as possible, thus greatly improving the survival rate of cancer patients. Individualized drug diagnosis for cancer patients to provide a more accurate cancer treatment program. Tumor recovery was monitored to assess the risk of recurrence.
In this paper, the current status and future development trend of hematoncology testing in China market are studied, focusing on the analysis of the companies that play an important role in the Chinese market, and focusing on the revenue, market share, market positioning, development plans, products and services of these companies in the Chinese market.
Highlights
The global Hemato Oncology Testing market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
In Chinese Market, Hemato Oncology Testing key players include Roche, Berry Genomics, Burning Rock Dx, BGI, Genetron, etc. Global top 5 manufacturers hold a share over 28%.
In terms of product, ctDNA Testing is the largest segment, with a share over 71%. And in terms of application, the largest application is Hospital, followed by Third Party Agency, Others.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Hemato Oncology Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemato Oncology Testing.
The Hemato Oncology Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Hemato Oncology Testing market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hemato Oncology Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Roche
- Berry Genomics
- Burning Rock Dx
- BGI
- Genetron
- Haplox
- Amoy Dx
- Genosaber
- YZY Biopharma
- Wondfo
Global markets are presented by Hemato Oncology Testing type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Hemato Oncology Testing are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Hemato Oncology Testing segment by Type
- ctDNA Testing
- CTC Testing
- Other Testing
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Hemato Oncology Testing market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Hemato Oncology Testing market.
Hemato Oncology Testing Segment by Application
- Hospital
- Third Party Agency
- Others
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Hemato Oncology Testing market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemato Oncology Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Hemato Oncology Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Hemato Oncology Testing industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemato Oncology Testing.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Hemato Oncology Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Frequently Asked Questions
- What factors will challenge the Product Name market growth?
- Which end-use segment will expand at the fastest CAGR in the Product Name market?
- Which are the emerging players in the Product Name market?
- How concentrated is the Product Name market?
- Which factors are positively contributing to the Product Name market growth?
- Which are the novel product innovations in the Product Name market?
- Which product segment will emerge as the most lucrative in the Product Name market?
- Which factors are increasing the competition in the Product Name market?
- Which are the strategic measures taken by the Product Name industry players?
- Which region will witness inactive growth during the forecast period?
- What key trends are likely to emerge in the Product Name market in the coming years?
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Hemato Oncology Testing Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Hemato Oncology Testing Revenue Market Share by Type (2018-2023)
Table 7. Global Hemato Oncology Testing Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Hemato Oncology Testing Revenue Market Share by Type (2024-2029)
Table 9. Global Hemato Oncology Testing Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Hemato Oncology Testing Revenue Market Share by Application (2018-2023)
Table 11. Global Hemato Oncology Testing Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Hemato Oncology Testing Revenue Market Share by Application (2024-2029)
Table 13. Global Hemato Oncology Testing Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Hemato Oncology Testing Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Hemato Oncology Testing Market Share by Region (2018-2023)
Table 16. Global Hemato Oncology Testing Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Hemato Oncology Testing Market Share by Region (2024-2029)
Table 18. Hemato Oncology Testing Market Trends
Table 19. Hemato Oncology Testing Market Drivers
Table 20. Hemato Oncology Testing Market Challenges
Table 21. Hemato Oncology Testing Market Restraints
Table 22. Global Top Hemato Oncology Testing Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Hemato Oncology Testing Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Hemato Oncology Testing Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Hemato Oncology Testing, Headquarters and Area Served
Table 26. Global Hemato Oncology Testing Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Hemato Oncology Testing by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Hemato Oncology Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Hemato Oncology Testing Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Hemato Oncology Testing Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Hemato Oncology Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Hemato Oncology Testing Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Hemato Oncology Testing Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Hemato Oncology Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Hemato Oncology Testing Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Hemato Oncology Testing Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Hemato Oncology Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Hemato Oncology Testing Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Hemato Oncology Testing Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Hemato Oncology Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Hemato Oncology Testing Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Hemato Oncology Testing Market Size by Country (2024-2029) & (US$ Million)
Table 45. Roche Company Detail
Table 46. Roche Business Overview
Table 47. Roche Hemato Oncology Testing Product
Table 48. Roche Revenue in Hemato Oncology Testing Business (2017-2022) & (US$ Million)
Table 49. Roche Recent Development
Table 50. Berry Genomics Company Detail
Table 51. Berry Genomics Business Overview
Table 52. Berry Genomics Hemato Oncology Testing Product
Table 53. Berry Genomics Revenue in Hemato Oncology Testing Business (2017-2022) & (US$ Million)
Table 54. Berry Genomics Recent Development
Table 55. Burning Rock Dx Company Detail
Table 56. Burning Rock Dx Business Overview
Table 57. Burning Rock Dx Hemato Oncology Testing Product
Table 58. Burning Rock Dx Revenue in Hemato Oncology Testing Business (2017-2022) & (US$ Million)
Table 59. Burning Rock Dx Recent Development
Table 60. BGI Company Detail
Table 61. BGI Business Overview
Table 62. BGI Hemato Oncology Testing Product
Table 63. BGI Revenue in Hemato Oncology Testing Business (2017-2022) & (US$ Million)
Table 64. BGI Recent Development
Table 65. Genetron Company Detail
Table 66. Genetron Business Overview
Table 67. Genetron Hemato Oncology Testing Product
Table 68. Genetron Revenue in Hemato Oncology Testing Business (2017-2022) & (US$ Million)
Table 69. Genetron Recent Development
Table 70. Haplox Company Detail
Table 71. Haplox Business Overview
Table 72. Haplox Hemato Oncology Testing Product
Table 73. Haplox Revenue in Hemato Oncology Testing Business (2017-2022) & (US$ Million)
Table 74. Haplox Recent Development
Table 75. Amoy Dx Company Detail
Table 76. Amoy Dx Business Overview
Table 77. Amoy Dx Hemato Oncology Testing Product
Table 78. Amoy Dx Revenue in Hemato Oncology Testing Business (2017-2022) & (US$ Million)
Table 79. Amoy Dx Recent Development
Table 80. Genosaber Company Detail
Table 81. Genosaber Business Overview
Table 82. Genosaber Hemato Oncology Testing Product
Table 83. Genosaber Revenue in Hemato Oncology Testing Business (2017-2022) & (US$ Million)
Table 84. Genosaber Recent Development
Table 85. YZY Biopharma Company Detail
Table 86. YZY Biopharma Business Overview
Table 87. YZY Biopharma Hemato Oncology Testing Product
Table 88. YZY Biopharma Revenue in Hemato Oncology Testing Business (2017-2022) & (US$ Million)
Table 89. YZY Biopharma Recent Development
Table 90. Wondfo Company Detail
Table 91. Wondfo Business Overview
Table 92. Wondfo Hemato Oncology Testing Product
Table 93. Wondfo Revenue in Hemato Oncology Testing Business (2017-2022) & (US$ Million)
Table 94. Wondfo Recent Development
Table 95. Roche Company Information
Table 96. Roche Business Overview
Table 97. Roche Hemato Oncology Testing Revenue in Hemato Oncology Testing Business (2018-2023) & (US$ Million)
Table 98. Roche Revenue in Hemato Oncology Testing Business (2018-2023) & (US$ Million) Portfolio
Table 99. Roche Recent Development
Table 100. Berry Genomics Company Information
Table 101. Berry Genomics Business Overview
Table 102. Berry Genomics Hemato Oncology Testing Revenue in Hemato Oncology Testing Business (2018-2023) & (US$ Million)
Table 103. Berry Genomics Revenue in Hemato Oncology Testing Business (2018-2023) & (US$ Million) Portfolio
Table 104. Berry Genomics Recent Development
Table 105. Burning Rock Dx Company Information
Table 106. Burning Rock Dx Business Overview
Table 107. Burning Rock Dx Hemato Oncology Testing Revenue in Hemato Oncology Testing Business (2018-2023) & (US$ Million)
Table 108. Burning Rock Dx Revenue in Hemato Oncology Testing Business (2018-2023) & (US$ Million) Portfolio
Table 109. Burning Rock Dx Recent Development
Table 110. BGI Company Information
Table 111. BGI Business Overview
Table 112. BGI Hemato Oncology Testing Revenue in Hemato Oncology Testing Business (2018-2023) & (US$ Million)
Table 113. BGI Revenue in Hemato Oncology Testing Business (2018-2023) & (US$ Million) Portfolio
Table 114. BGI Recent Development
Table 115. Genetron Company Information
Table 116. Genetron Business Overview
Table 117. Genetron Hemato Oncology Testing Revenue in Hemato Oncology Testing Business (2018-2023) & (US$ Million)
Table 118. Genetron Revenue in Hemato Oncology Testing Business (2018-2023) & (US$ Million) Portfolio
Table 119. Genetron Recent Development
Table 120. Haplox Company Information
Table 121. Haplox Business Overview
Table 122. Haplox Hemato Oncology Testing Revenue in Hemato Oncology Testing Business (2018-2023) & (US$ Million)
Table 123. Haplox Revenue in Hemato Oncology Testing Business (2018-2023) & (US$ Million) Portfolio
Table 124. Haplox Recent Development
Table 125. Amoy Dx Company Information
Table 126. Amoy Dx Business Overview
Table 127. Amoy Dx Hemato Oncology Testing Revenue in Hemato Oncology Testing Business (2018-2023) & (US$ Million)
Table 128. Amoy Dx Revenue in Hemato Oncology Testing Business (2018-2023) & (US$ Million) Portfolio
Table 129. Amoy Dx Recent Development
Table 130. Genosaber Company Information
Table 131. Genosaber Business Overview
Table 132. Genosaber Hemato Oncology Testing Revenue in Hemato Oncology Testing Business (2018-2023) & (US$ Million)
Table 133. Genosaber Revenue in Hemato Oncology Testing Business (2018-2023) & (US$ Million) Portfolio
Table 134. Genosaber Recent Development
Table 135. YZY Biopharma Company Information
Table 136. YZY Biopharma Business Overview
Table 137. YZY Biopharma Hemato Oncology Testing Revenue in Hemato Oncology Testing Business (2018-2023) & (US$ Million)
Table 138. YZY Biopharma Revenue in Hemato Oncology Testing Business (2018-2023) & (US$ Million) Portfolio
Table 139. YZY Biopharma Recent Development
Table 140. Wondfo Company Information
Table 141. Wondfo Business Overview
Table 142. Wondfo Hemato Oncology Testing Revenue in Hemato Oncology Testing Business (2018-2023) & (US$ Million)
Table 143. Wondfo Revenue in Hemato Oncology Testing Business (2018-2023) & (US$ Million) Portfolio
Table 144. Wondfo Recent Development
Table 145. Authors 12. List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Hemato Oncology Testing Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Hemato Oncology Testing Revenue Market Share by Type (2018-2023)
Table 7. Global Hemato Oncology Testing Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Hemato Oncology Testing Revenue Market Share by Type (2024-2029)
Table 9. Global Hemato Oncology Testing Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Hemato Oncology Testing Revenue Market Share by Application (2018-2023)
Table 11. Global Hemato Oncology Testing Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Hemato Oncology Testing Revenue Market Share by Application (2024-2029)
Table 13. Global Hemato Oncology Testing Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Hemato Oncology Testing Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Hemato Oncology Testing Market Share by Region (2018-2023)
Table 16. Global Hemato Oncology Testing Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Hemato Oncology Testing Market Share by Region (2024-2029)
Table 18. Hemato Oncology Testing Market Trends
Table 19. Hemato Oncology Testing Market Drivers
Table 20. Hemato Oncology Testing Market Challenges
Table 21. Hemato Oncology Testing Market Restraints
Table 22. Global Top Hemato Oncology Testing Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Hemato Oncology Testing Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Hemato Oncology Testing Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Hemato Oncology Testing, Headquarters and Area Served
Table 26. Global Hemato Oncology Testing Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Hemato Oncology Testing by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Hemato Oncology Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Hemato Oncology Testing Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Hemato Oncology Testing Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Hemato Oncology Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Hemato Oncology Testing Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Hemato Oncology Testing Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Hemato Oncology Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Hemato Oncology Testing Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Hemato Oncology Testing Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Hemato Oncology Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Hemato Oncology Testing Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Hemato Oncology Testing Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Hemato Oncology Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Hemato Oncology Testing Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Hemato Oncology Testing Market Size by Country (2024-2029) & (US$ Million)
Table 45. Roche Company Detail
Table 46. Roche Business Overview
Table 47. Roche Hemato Oncology Testing Product
Table 48. Roche Revenue in Hemato Oncology Testing Business (2017-2022) & (US$ Million)
Table 49. Roche Recent Development
Table 50. Berry Genomics Company Detail
Table 51. Berry Genomics Business Overview
Table 52. Berry Genomics Hemato Oncology Testing Product
Table 53. Berry Genomics Revenue in Hemato Oncology Testing Business (2017-2022) & (US$ Million)
Table 54. Berry Genomics Recent Development
Table 55. Burning Rock Dx Company Detail
Table 56. Burning Rock Dx Business Overview
Table 57. Burning Rock Dx Hemato Oncology Testing Product
Table 58. Burning Rock Dx Revenue in Hemato Oncology Testing Business (2017-2022) & (US$ Million)
Table 59. Burning Rock Dx Recent Development
Table 60. BGI Company Detail
Table 61. BGI Business Overview
Table 62. BGI Hemato Oncology Testing Product
Table 63. BGI Revenue in Hemato Oncology Testing Business (2017-2022) & (US$ Million)
Table 64. BGI Recent Development
Table 65. Genetron Company Detail
Table 66. Genetron Business Overview
Table 67. Genetron Hemato Oncology Testing Product
Table 68. Genetron Revenue in Hemato Oncology Testing Business (2017-2022) & (US$ Million)
Table 69. Genetron Recent Development
Table 70. Haplox Company Detail
Table 71. Haplox Business Overview
Table 72. Haplox Hemato Oncology Testing Product
Table 73. Haplox Revenue in Hemato Oncology Testing Business (2017-2022) & (US$ Million)
Table 74. Haplox Recent Development
Table 75. Amoy Dx Company Detail
Table 76. Amoy Dx Business Overview
Table 77. Amoy Dx Hemato Oncology Testing Product
Table 78. Amoy Dx Revenue in Hemato Oncology Testing Business (2017-2022) & (US$ Million)
Table 79. Amoy Dx Recent Development
Table 80. Genosaber Company Detail
Table 81. Genosaber Business Overview
Table 82. Genosaber Hemato Oncology Testing Product
Table 83. Genosaber Revenue in Hemato Oncology Testing Business (2017-2022) & (US$ Million)
Table 84. Genosaber Recent Development
Table 85. YZY Biopharma Company Detail
Table 86. YZY Biopharma Business Overview
Table 87. YZY Biopharma Hemato Oncology Testing Product
Table 88. YZY Biopharma Revenue in Hemato Oncology Testing Business (2017-2022) & (US$ Million)
Table 89. YZY Biopharma Recent Development
Table 90. Wondfo Company Detail
Table 91. Wondfo Business Overview
Table 92. Wondfo Hemato Oncology Testing Product
Table 93. Wondfo Revenue in Hemato Oncology Testing Business (2017-2022) & (US$ Million)
Table 94. Wondfo Recent Development
Table 95. Roche Company Information
Table 96. Roche Business Overview
Table 97. Roche Hemato Oncology Testing Revenue in Hemato Oncology Testing Business (2018-2023) & (US$ Million)
Table 98. Roche Revenue in Hemato Oncology Testing Business (2018-2023) & (US$ Million) Portfolio
Table 99. Roche Recent Development
Table 100. Berry Genomics Company Information
Table 101. Berry Genomics Business Overview
Table 102. Berry Genomics Hemato Oncology Testing Revenue in Hemato Oncology Testing Business (2018-2023) & (US$ Million)
Table 103. Berry Genomics Revenue in Hemato Oncology Testing Business (2018-2023) & (US$ Million) Portfolio
Table 104. Berry Genomics Recent Development
Table 105. Burning Rock Dx Company Information
Table 106. Burning Rock Dx Business Overview
Table 107. Burning Rock Dx Hemato Oncology Testing Revenue in Hemato Oncology Testing Business (2018-2023) & (US$ Million)
Table 108. Burning Rock Dx Revenue in Hemato Oncology Testing Business (2018-2023) & (US$ Million) Portfolio
Table 109. Burning Rock Dx Recent Development
Table 110. BGI Company Information
Table 111. BGI Business Overview
Table 112. BGI Hemato Oncology Testing Revenue in Hemato Oncology Testing Business (2018-2023) & (US$ Million)
Table 113. BGI Revenue in Hemato Oncology Testing Business (2018-2023) & (US$ Million) Portfolio
Table 114. BGI Recent Development
Table 115. Genetron Company Information
Table 116. Genetron Business Overview
Table 117. Genetron Hemato Oncology Testing Revenue in Hemato Oncology Testing Business (2018-2023) & (US$ Million)
Table 118. Genetron Revenue in Hemato Oncology Testing Business (2018-2023) & (US$ Million) Portfolio
Table 119. Genetron Recent Development
Table 120. Haplox Company Information
Table 121. Haplox Business Overview
Table 122. Haplox Hemato Oncology Testing Revenue in Hemato Oncology Testing Business (2018-2023) & (US$ Million)
Table 123. Haplox Revenue in Hemato Oncology Testing Business (2018-2023) & (US$ Million) Portfolio
Table 124. Haplox Recent Development
Table 125. Amoy Dx Company Information
Table 126. Amoy Dx Business Overview
Table 127. Amoy Dx Hemato Oncology Testing Revenue in Hemato Oncology Testing Business (2018-2023) & (US$ Million)
Table 128. Amoy Dx Revenue in Hemato Oncology Testing Business (2018-2023) & (US$ Million) Portfolio
Table 129. Amoy Dx Recent Development
Table 130. Genosaber Company Information
Table 131. Genosaber Business Overview
Table 132. Genosaber Hemato Oncology Testing Revenue in Hemato Oncology Testing Business (2018-2023) & (US$ Million)
Table 133. Genosaber Revenue in Hemato Oncology Testing Business (2018-2023) & (US$ Million) Portfolio
Table 134. Genosaber Recent Development
Table 135. YZY Biopharma Company Information
Table 136. YZY Biopharma Business Overview
Table 137. YZY Biopharma Hemato Oncology Testing Revenue in Hemato Oncology Testing Business (2018-2023) & (US$ Million)
Table 138. YZY Biopharma Revenue in Hemato Oncology Testing Business (2018-2023) & (US$ Million) Portfolio
Table 139. YZY Biopharma Recent Development
Table 140. Wondfo Company Information
Table 141. Wondfo Business Overview
Table 142. Wondfo Hemato Oncology Testing Revenue in Hemato Oncology Testing Business (2018-2023) & (US$ Million)
Table 143. Wondfo Revenue in Hemato Oncology Testing Business (2018-2023) & (US$ Million) Portfolio
Table 144. Wondfo Recent Development
Table 145. Authors 12. List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Hemato Oncology Testing Product Picture
Figure 5. Global Hemato Oncology Testing Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Hemato Oncology Testing Market Share by Type: 2022 VS 2029
Figure 7. ctDNA Testing Product Picture
Figure 8. CTC Testing Product Picture
Figure 9. Other Testing Product Picture
Figure 10. Global Hemato Oncology Testing Market Size by Application (2023-2029) & (US$ Million)
Figure 11. Global Hemato Oncology Testing Market Share by Application: 2022 VS 2029
Figure 12. Hospital Product Picture
Figure 13. Third Party Agency Product Picture
Figure 14. Others Product Picture
Figure 15. Global Hemato Oncology Testing Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Hemato Oncology Testing Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Hemato Oncology Testing Market Share by Region: 2022 VS 2029
Figure 18. Global Hemato Oncology Testing Market Share by Players in 2022
Figure 19. Global Hemato Oncology Testing Players, Date of Enter into This Industry
Figure 20. Global Top 5 and 10 Hemato Oncology Testing Players Market Share by Revenue in 2022
Figure 21. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 22. North America Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. North America Hemato Oncology Testing Market Share by Country (2018-2029)
Figure 24. United States Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Canada Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Hemato Oncology Testing Market Share by Country (2018-2029)
Figure 28. Germany Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Asia-Pacific Hemato Oncology Testing Market Share by Country (2018-2029)
Figure 36. China Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Japan Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. South Korea Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Southeast Asia Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. India Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Australia Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Latin America Hemato Oncology Testing Market Share by Country (2018-2029)
Figure 44. Mexico Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Brazil Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Hemato Oncology Testing Market Share by Country (2018-2029)
Figure 48. Turkey Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Saudi Arabia Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. UAE Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Roche Revenue Growth Rate in Hemato Oncology Testing Business (2018-2023)
Figure 52. Berry Genomics Revenue Growth Rate in Hemato Oncology Testing Business (2018-2023)
Figure 53. Burning Rock Dx Revenue Growth Rate in Hemato Oncology Testing Business (2018-2023)
Figure 54. BGI Revenue Growth Rate in Hemato Oncology Testing Business (2018-2023)
Figure 55. Genetron Revenue Growth Rate in Hemato Oncology Testing Business (2018-2023)
Figure 56. Haplox Revenue Growth Rate in Hemato Oncology Testing Business (2018-2023)
Figure 57. Amoy Dx Revenue Growth Rate in Hemato Oncology Testing Business (2018-2023)
Figure 58. Genosaber Revenue Growth Rate in Hemato Oncology Testing Business (2018-2023)
Figure 59. YZY Biopharma Revenue Growth Rate in Hemato Oncology Testing Business (2018-2023)
Figure 60. Wondfo Revenue Growth Rate in Hemato Oncology Testing Business (2018-2023)
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Hemato Oncology Testing Product Picture
Figure 5. Global Hemato Oncology Testing Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Hemato Oncology Testing Market Share by Type: 2022 VS 2029
Figure 7. ctDNA Testing Product Picture
Figure 8. CTC Testing Product Picture
Figure 9. Other Testing Product Picture
Figure 10. Global Hemato Oncology Testing Market Size by Application (2023-2029) & (US$ Million)
Figure 11. Global Hemato Oncology Testing Market Share by Application: 2022 VS 2029
Figure 12. Hospital Product Picture
Figure 13. Third Party Agency Product Picture
Figure 14. Others Product Picture
Figure 15. Global Hemato Oncology Testing Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Hemato Oncology Testing Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Hemato Oncology Testing Market Share by Region: 2022 VS 2029
Figure 18. Global Hemato Oncology Testing Market Share by Players in 2022
Figure 19. Global Hemato Oncology Testing Players, Date of Enter into This Industry
Figure 20. Global Top 5 and 10 Hemato Oncology Testing Players Market Share by Revenue in 2022
Figure 21. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 22. North America Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. North America Hemato Oncology Testing Market Share by Country (2018-2029)
Figure 24. United States Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Canada Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Hemato Oncology Testing Market Share by Country (2018-2029)
Figure 28. Germany Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Asia-Pacific Hemato Oncology Testing Market Share by Country (2018-2029)
Figure 36. China Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Japan Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. South Korea Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Southeast Asia Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. India Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Australia Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Latin America Hemato Oncology Testing Market Share by Country (2018-2029)
Figure 44. Mexico Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Brazil Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Hemato Oncology Testing Market Share by Country (2018-2029)
Figure 48. Turkey Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Saudi Arabia Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. UAE Hemato Oncology Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Roche Revenue Growth Rate in Hemato Oncology Testing Business (2018-2023)
Figure 52. Berry Genomics Revenue Growth Rate in Hemato Oncology Testing Business (2018-2023)
Figure 53. Burning Rock Dx Revenue Growth Rate in Hemato Oncology Testing Business (2018-2023)
Figure 54. BGI Revenue Growth Rate in Hemato Oncology Testing Business (2018-2023)
Figure 55. Genetron Revenue Growth Rate in Hemato Oncology Testing Business (2018-2023)
Figure 56. Haplox Revenue Growth Rate in Hemato Oncology Testing Business (2018-2023)
Figure 57. Amoy Dx Revenue Growth Rate in Hemato Oncology Testing Business (2018-2023)
Figure 58. Genosaber Revenue Growth Rate in Hemato Oncology Testing Business (2018-2023)
Figure 59. YZY Biopharma Revenue Growth Rate in Hemato Oncology Testing Business (2018-2023)
Figure 60. Wondfo Revenue Growth Rate in Hemato Oncology Testing Business (2018-2023)
